AVAH Share Price Performance
US$6.75
2.28 (51.01%)
34.1% undervalued intrinsic discount
US$10.25
Fair Value
Price US$6.75
AnalystConsensusTarget US$10.25
AnalystLowTarget US$7.00
AnalystHighTarget US$12.94
Fair ValueUS$10.25
Share Pricen/a
Aveanna Healthcare Holdings Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 11 Fair Values set on narratives written by author
AVAH Community Narratives
AN
Fair Value
·Fair Value US$10.25 34.1% undervalued intrinsic discount
Improved Earnings Visibility and Liquidity Changes Will Shape Capacity Expansion
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
Fair Value
·Fair Value US$7 3.6% undervalued intrinsic discount
Medicaid Cuts And Rising Wages Will Erode Margins
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value US$12.94 47.8% undervalued intrinsic discount
Aging Demographics Will Expand The Home Care Market
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Aging Demographics Will Expand The Home Care Market
Key Takeaways Capacity-constrained home healthcare demand, payer relationships, and transition from institutional care position Aveanna for sustained market share gains and above-industry growth. Margin expansion and free cash flow are driven by preferred payer conversions, digital investments, and synergistic acquisitions in a consolidating home care market.Read more
AN
US$12.94
47.8% undervalued intrinsic discount
Fair Value
Revenue
5.8% p.a.
Profit Margin
4.98%
Future PE
29.71x
Price in 2029
US$16.01
Medicaid Cuts And Rising Wages Will Erode Margins
Key Takeaways Deep dependence on government reimbursement and exposure to regulatory shifts create persistent headwinds for revenue stability and profitability. Rising labor costs, technological disruption, and industry consolidation collectively threaten margins, contract terms, and long-term earnings growth.Read more
AN
US$7
3.6% undervalued intrinsic discount
Fair Value
Revenue
5.49% p.a.
Profit Margin
4.74%
Future PE
17.06x
Price in 2029
US$8.67
Improved Earnings Visibility and Liquidity Changes Will Shape Capacity Expansion
Key Takeaways Strong demand for in-home healthcare and a growing aging population are expanding Aveanna's market opportunity and supporting sustained long-term growth. Strategic payer relationships, efficiency initiatives, and recent acquisitions are boosting margins, cash flow, and future earnings potential.Read more
AN
US$10.25
34.1% undervalued intrinsic discount
Fair Value
Revenue
5.38% p.a.
Profit Margin
4.13%
Future PE
28.78x
Price in 2029
US$12.7
Trending Discussion
Recently Updated Narratives
AN
AVAH: Future EBITDA Expansion Will Be Driven By Rebased Margins And Higher P/E Multiple
Fair Value: US$12.94 47.8% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AVAH: Cautious Earnings Outlook Will Test Reimbursement Assumptions And Margin Resilience
Fair Value: US$7 3.6% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AVAH: Refined Discount Rate And Earnings Visibility May Support Repricing Potential
Fair Value: US$10.25 34.1% undervalued intrinsic discount
5 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Aveanna Healthcare Holdings Inc. Key Details
Last Reported Earnings
Jan 03, 2026
Next Reporting Earnings
May 14, 2026
- 1.03
- 33.05%
- 9.25%
- 753.7%
About AVAH
- Founded
- 2016
- Employees
- 19500
- CEO
- WebsiteView website
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
